Rare respiratory diseases are ready for primetime: from Rare Disease Day to the European Reference Networks

Rare diseases are life-threatening or chronically debilitating conditions which are of such low prevalence (fewer than 1 in 2000 people) that special combined efforts are needed to address them [1]. Launched in 2008 by Rare Diseases Europe (EURORDIS), a non-governmental patient-driven alliance representing 733 rare disease patient organisations in 64 countries, Rare Disease Day (figure 1) takes place on the last day of February each year. The main objective of Rare Disease Day is to raise awareness amongst the general public and decision-makers about rare diseases and their impact on patients' lives [2]. In 2017, Rare Disease Day will emphasise that research brings hope to people living with a rare disease [2]. Indeed, due to the rarity and diversity of rare diseases, research needs to be international to ensure that experts, researchers and clinicians are connected, that clinical trials are multinational, and that patients can benefit from the pooling of resources across borders [2]. The ERN-LUNG network is currently made up of 60 centres in 12 countries and is focused on rare respiratory diseases http://ow.ly/CG0d3089xDC

[1]  M. Eyries,et al.  Genetic analyses in a cohort of children with pulmonary hypertension , 2016, European Respiratory Journal.

[2]  J. Moss,et al.  The changing face of a rare disease: lymphangioleiomyomatosis , 2015, European Respiratory Journal.

[3]  C. Kuehni,et al.  Clinical manifestations in primary ciliary dyskinesia: systematic review and meta-analysis , 2016, European Respiratory Journal.

[4]  R. Epaud,et al.  Management of children with interstitial lung diseases: the difficult issue of acute exacerbations , 2016, European Respiratory Journal.

[5]  H. Collard,et al.  Acute exacerbation of idiopathic pulmonary fibrosis: shifting the paradigm , 2015, European Respiratory Journal.

[6]  Stefano Aliberti,et al.  Management of bronchiectasis in adults , 2015, European Respiratory Journal.

[7]  V. Vorselaars,et al.  Follow-up of pulmonary right-to-left shunt in hereditary haemorrhagic telangiectasia , 2016, European Respiratory Journal.

[8]  E. Roach,et al.  Tuberous sclerosis complex. , 2015, Handbook of clinical neurology.

[9]  M. Frydenberg,et al.  Risk of hypersensitivity pneumonitis and interstitial lung diseases among pigeon breeders , 2016, European Respiratory Journal.

[10]  J. Ryu Faculty of 1000 evaluation for An official European Respiratory Society/American Thoracic Society research statement: interstitial pneumonia with autoimmune features. , 2016 .

[11]  M. Humbert,et al.  Toward better management of rare and orphan pulmonary diseases , 2016, European Respiratory Journal.

[12]  K. Batra,et al.  Telomere-related lung fibrosis is diagnostically heterogeneous but uniformly progressive , 2016, European Respiratory Journal.

[13]  J. Chalmers,et al.  Research priorities in bronchiectasis: a consensus statement from the EMBARC Clinical Research Collaboration , 2016, European Respiratory Journal.

[14]  J. Pépin,et al.  Definition, discrimination, diagnosis and treatment of central breathing disturbances during sleep , 2017, European Respiratory Journal.

[15]  P. Burgel,et al.  Future trends in cystic fibrosis demography in 34 European countries , 2015, European Respiratory Journal.

[16]  M. Humbert,et al.  Pulmonary arterial hypertension , 2013, Orphanet Journal of Rare Diseases.

[17]  G. Canonica,et al.  Public awareness on cystic fibrosis: results from a national pragmatic survey , 2015, European Respiratory Journal.

[18]  M. Humbert,et al.  Genetic counselling in a national referral centre for pulmonary hypertension , 2015, European Respiratory Journal.

[19]  M. Humbert,et al.  Rare (pulmonary) disease day: “feeding the breath, energy for life!” , 2015, European Respiratory Journal.

[20]  Simon Gibbs,et al.  2015 ESC/ERS Guidelines for the Diagnosis and Treatment of Pulmonary Hypertension. , 2016, Revista espanola de cardiologia.

[21]  P. Lackie,et al.  Accuracy of diagnostic testing in primary ciliary dyskinesia , 2015, European Respiratory Journal.

[22]  N. Kamel European reference networks: moving towards a tangible outcome of the European Union's cross-border healthcare directive? , 2016, European Respiratory Journal.

[23]  D. Maucort-Boulch,et al.  Sarcoidosis-related mortality in France: a multiple-cause-of-death analysis , 2016, European Respiratory Journal.

[24]  R. Slama,et al.  Chronic effects of air pollution on lung function after lung transplantation in the Systems prediction of Chronic Lung Allograft Dysfunction (SysCLAD) study , 2017, European Respiratory Journal.

[25]  D. Sengupta,et al.  Congenital diaphragmatic hernia. , 1963, The Indian journal of child health.

[26]  M. Humbert,et al.  Pulmonary arterial hypertension in patients treated with interferon , 2014, European Respiratory Journal.

[27]  M. Humbert,et al.  BMPR2 mutation status influences bronchial vascular changes in pulmonary arterial hypertension , 2016, European Respiratory Journal.

[28]  Thierry Troosters,et al.  An official European Respiratory Society/American Thoracic Society technical standard: field walking tests in chronic respiratory disease , 2014, European Respiratory Journal.

[29]  H. Collard,et al.  Rare pulmonary diseases and orphan drugs: where do we stand and where are we going to? , 2015, European Respiratory Review.

[30]  T. Greulich,et al.  The prevalence of diagnosed α1-antitrypsin deficiency and its comorbidities: results from a large population-based database , 2017, European Respiratory Journal.

[31]  A. Quittner,et al.  A quality-of-life measure for adults with primary ciliary dyskinesia: QOL–PCD , 2015, European Respiratory Journal.

[32]  Jianhua Yao,et al.  Severity and outcome of cystic lung disease in women with tuberous sclerosis complex , 2015, European Respiratory Journal.

[33]  G. Verleden,et al.  An association of particulate air pollution and traffic exposure with mortality after lung transplantation in Europe , 2017, European Respiratory Journal.

[34]  T. Welte,et al.  Report of the European Respiratory Society/European Cystic Fibrosis Society task force on the care of adults with cystic fibrosis , 2015, European Respiratory Journal.

[35]  L. Behan,et al.  Diagnosing primary ciliary dyskinesia: an international patient perspective , 2016, European Respiratory Journal.

[36]  G. Sotgiu,et al.  Clinical phenotypes in adult patients with bronchiectasis , 2016, European Respiratory Journal.

[37]  A. Nicholson,et al.  Nonspecific interstitial pneumonia: survival is influenced by the underlying cause , 2014, European Respiratory Journal.

[38]  Y. Cozier Assessing the worldwide epidemiology of sarcoidosis: challenges and future directions , 2016, European Respiratory Journal.

[39]  D. Lynch,et al.  An official European Respiratory Society/American Thoracic Society research statement: interstitial pneumonia with autoimmune features , 2015, European Respiratory Journal.

[40]  H. Omran,et al.  An international registry for primary ciliary dyskinesia , 2015, European Respiratory Journal.

[41]  D. Gossot,et al.  Recurrent NRAS mutations in pulmonary Langerhans cell histiocytosis , 2016, European Respiratory Journal.

[42]  G. Verleden,et al.  An international ISHLT/ATS/ERS clinical practice guideline: diagnosis and management of bronchiolitis obliterans syndrome , 2014, European Respiratory Journal.

[43]  J. Grunewald,et al.  Sarcoidosis incidence and prevalence: a nationwide register-based assessment in Sweden , 2016, European Respiratory Journal.

[44]  T. Welte,et al.  Management of patients with idiopathic pulmonary fibrosis in clinical practice: the INSIGHTS-IPF registry , 2015, European Respiratory Journal.

[45]  W. Wuyts,et al.  European IPF Patient Charter: unmet needs and a call to action for healthcare policymakers , 2015, European Respiratory Journal.

[46]  J. Sundquist,et al.  Incidence and familial risk of pleural mesothelioma in Sweden: a national cohort study , 2016, European Respiratory Journal.

[47]  H. Omran,et al.  European Respiratory Society guidelines for the diagnosis of primary ciliary dyskinesia , 2017, European Respiratory Journal.

[48]  T. Fingerlin,et al.  Beryllium-induced lung disease exhibits expression profiles similar to sarcoidosis , 2016, European Respiratory Journal.

[49]  G. Koch,et al.  A new era in idiopathic pulmonary fibrosis: considerations for future clinical trials , 2015, European Respiratory Journal.

[50]  G. A. Whitmore,et al.  A contemporary survival analysis of individuals with cystic fibrosis: a cohort study , 2014, European Respiratory Journal.

[51]  P. Revy,et al.  Prevalence and characteristics of TERT and TERC mutations in suspected genetic pulmonary fibrosis , 2016, European Respiratory Journal.

[52]  M. Humbert,et al.  Respiratory manifestations of eosinophilic granulomatosis with polyangiitis (Churg–Strauss) , 2016, European Respiratory Journal.